Vanberra Signal

Neolexon

Curated by Signal

App for aphasia therapy

Overview

Neolexon is an app for aphasia therapy. The app offers personalized therapy exercises created by the therapists and the progress in therapy is recorded. The exercises contain training for understanding, speaking, reading and writing. The difficulty of the exercises is set by the speech therapist. A range of aids supports domestic practice. The data can be tracked by the therapist via the therapist app.

Key facts

Founded
2017
Headquarters
Munich, Germany

Business model

Contact

Open roles

2 roles
  • Therapeut:in als Customer-Solutions Manager:in (m/w/d) | Digital Health & Sprachtherapie

    Munich, Bavaria, Germany · On-site · Internship

  • React Native Developer mit UI/UX-Fokus (m/w/d) | Digital Health & Sprachtherapie

    Munich, Bavaria, Germany · On-site · Internship

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Online telemedicine and population health management platform

    Health TechnologyBerlin, Germany
  • Provider of AI-based decision support tool for breast cancer

    Health TechnologyWurzburg, Germany

About Neolexon

What does Neolexon do?

Neolexon is an app for aphasia therapy.

Where is Neolexon headquartered?

Neolexon is headquartered in Munich, Germany.

When was Neolexon founded?

Neolexon was founded in 2017.

Which sector is Neolexon in?

Neolexon operates in Health Technology.

Who are Neolexon's competitors?

Companies similar to Neolexon include Medloop, OncoGenomX, and Neue Heilmittelrichtline.

Is Neolexon hiring?

Yes. Neolexon has 2 open roles listed on Vanberra Signal.